Skip to main content
Clinical Trials/IRCT201308181159N9
IRCT201308181159N9CompletedPhase 3

Comparison of the efficacy and safety of Q-Switch 1,064 nm Nd:YAG Laser with and without carbon photo enhancer lotion on reducing skin pigmentation in patients with Melasma referred to Skin and Stem cell research center of Tehran University of Medical Sciences

Vice Chancellor for Research, Tehran University of Medical Sciences0 sites43 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
43

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 85 years (—)
Sex
All

Inclusion Criteria

  • Age between 18 and 85 years old; Fitzpatrick skin type I-V; symmetric distribution of melasma the in both sides of patient's face;
  • Exclusion criteria: -usage of pigment reducing topical treatments 2 weeks prior to the study -usage of peeling agents 2 weeks prior to the study -laser therapy for melasma 1 month prior to the study, and solarium usage one month prior to the treatment.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice Chancellor for Research, Tehran University of Medical Sciences

Similar Trials